81 related articles for article (PubMed ID: 9022015)
1. Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.
Burrows SR; Silins SL; Cross SM; Peh CA; Rischmueller M; Burrows JM; Elliott SL; McCluskey J
Eur J Immunol; 1997 Jan; 27(1):178-82. PubMed ID: 9022015
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
4. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
Burrows SR; Khanna R; Burrows JM; Moss DJ
J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
[TBL] [Abstract][Full Text] [Related]
5. The shaping of T cell receptor recognition by self-tolerance.
Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
[TBL] [Abstract][Full Text] [Related]
6. A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
Reali E; Guerrini R; Marastoni M; Tomatis R; Masucci MG; Traniello S; Gavioli R
J Immunol; 1999 Jan; 162(1):106-13. PubMed ID: 9886375
[TBL] [Abstract][Full Text] [Related]
7. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
[TBL] [Abstract][Full Text] [Related]
8. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
Silins SL; Cross SM; Krauer KG; Moss DJ; Schmidt CW; Misko IS
J Clin Invest; 1998 Oct; 102(8):1551-8. PubMed ID: 9788968
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
[TBL] [Abstract][Full Text] [Related]
10. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
Murray RJ; Brooks JM; Rickinson AB; Rowe M
Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661
[TBL] [Abstract][Full Text] [Related]
11. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
Turcanová V; Höllsberg P
J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
13. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
[TBL] [Abstract][Full Text] [Related]
14. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
Mifsud NA; Nguyen TH; Tait BD; Kotsimbos TC
Transplantation; 2010 Dec; 90(12):1439-49. PubMed ID: 21042237
[TBL] [Abstract][Full Text] [Related]
16. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
D'Orsogna LJ; van den Heuvel H; van der Meer-Prins EM; Roelen DL; Doxiadis II; Claas FH
J Immunol; 2012 Nov; 189(10):4825-31. PubMed ID: 23077240
[TBL] [Abstract][Full Text] [Related]
19. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
[TBL] [Abstract][Full Text] [Related]
20. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
Levitsky V; de Campos-Lima PO; Frisan T; Masucci MG
J Immunol; 1998 Jul; 161(2):594-601. PubMed ID: 9670932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]